Although STAT3 inhibition alone retains some pro-apoptotic activity, as previously shown in studies involving STAT3-dependent leukemias [76,92,93], its contribution to the synergistic effect is clearly potentiated by a functional p53 axis. The gene discussed is STAT3; the disease is leukemia.